Abstract:Hypertension, Ahead of Print. Background:Endothelial dysfunction plays a crucial role in aortic remodeling. Aerobic glycolysis and endothelial-to-mesenchymal transition (EndoMT) have, respectively, been suggested to contribute to endothelial dysfunction in many cardiovascular diseases. Here, we tested the hypothesis that glycolytic reprogramming is critical for EndoMT induction in aortic remodeling through an epigenetic mechanism mediated by a transcriptional corepressor CtBP1 (C-terminal binding protein 1), a sensor of glycolysis-derived NADH.Methods:EndoMT program, aortic remodeling, and endothelial expression of the glycolytic activator PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3) were evaluated in Ang (angiotensin) II–infused mice. Mice with endothelial-specificPfkfb3deficiency or CtBP1 inactivation, immunoprecipitation, chromatin immunoprecipitation, and luciferase reporter assay were employed to elucidate whether and how PFKFB3/CtBP1 epigenetically controls EndoMT.Results:The EndoMT program and increased endothelial PFKFB3 expression were induced in remodeled thoracic aortas. In TGF (transforming growth factor)-β–treated human endothelial cells, activated SMAD2/3 transcriptionally upregulated PFKFB3 expression. In turn, the TGF-β/SMAD signaling and EndoMT were compromised by silencing or inhibition of PFKFB3. Mechanistic studies revealed that PFKFB3-mediated glycolysis increased NADH content and activated the NADH-sensitive CtBP1. Through interaction with the transcription repressor E2F4, CtBP1 enhanced E2F4-mediated transcriptional repression of SMURF2 (SMAD ubiquitin regulatory factor 2), a negative regulator of TGF-β/SMAD2 signaling. Additionally, EC-specificPfkfb3deficiency or CtBP1 inactivation in mice led to attenuated Ang II–induced aortic remodeling.Conclusions:Our results demonstrate a glycolysis-mediated positive feedback loop of the TGF-β signaling to induce EndoMT and indicate that therapeutically targeting endothelial PFKFB3 or CtBP1 activity could provide a basis for treating EndoMT-linked aortic remodeling.

A6645 Sirtuin 3-Mediated Glycolysis Enhancing During Angiotension II-induced Endothelial-to-mesenchymal Transition

Sirtuin 3 Governs Autophagy‐dependent Glycolysis During Angiotensin II‐induced Endothelial‐to‐mesenchymal Transition

Acetate Controls Endothelial-to-mesenchymal Transition

High Glucose And Free Fatty Acids Induce Endothelial Progenitor Cell Senescence Via Pgc-1 Alpha/Sirt1 Signaling Pathway

Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.

Glycolysis Promotes Angiotensin II–Induced Aortic Remodeling Through Regulating Endothelial-to-Mesenchymal Transition via the Corepressor C-Terminal Binding Protein 1

SIRT3 (Sirtuin-3) Prevents Ang II (angiotensin II)-Induced Macrophage Metabolic Switch Improving Perivascular Adipose Tissue Function.

[bp.08.02] the role of sirt3 mediated endothelial to mesenchymal transition in hypertensive renal fibrosis

A8324 Suppression of Endothelial to Mesenchymal Transition by SIRT3 Alleviated the Development of Hypertensive Renal Injury

Suppression of Endothelial-to-Mesenchymal Transition by SIRT (sirtuin) 3 Alleviated the Development of Hypertensive Renal Injury

Sirtuin 3 Deficiency Accelerates Angiotensin II-induced Skeletal Muscle Atrophy

Sirt3 Overexpression Alleviates Hyperglycemia-Induced Vascular Inflammation Through Regulating Redox Balance, Cell Survival, and AMPK-mediated Mitochondrial Homeostasis

Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis

Enhanced Aerobic Glycolysis by S-Nitrosoglutathione Via HIF-1α Associated GLUT1/Aldolase A Axis in Human Endothelial Cells

Sirt6-Mediated Endothelial-To-Mesenchymal Transition Contributes Toward Diabetic Cardiomyopathy Via The Notch1 Signaling Pathway

SIRT3 Prevents Angiotensin II-induced Renal Tubular Epithelial-Mesenchymal Transition by Ameliorating Oxidative Stress and Mitochondrial Dysfunction.

Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease

SIRT3 Mitigates High Glucose-Induced Damage in Retinal Microvascular Endothelial Cells Via OPA1-mediated Mitochondrial Dynamics

Mouse Sirt3 Promotes Autophagy in AngII-induced Myocardial Hypertrophy Through the Deacetylation of FoxO1.

AGEs Decreased SIRT3 Expression and SIRT3 Activation Protected AGEs-Induced EPCs’ Dysfunction and Strengthened Anti-oxidant Capacity

SIRT1 Inhibits TGF‐β‐induced Endothelial‐mesenchymal Transition in Human Endothelial Cells with Smad4 Deacetylation